NCT00285623View on ClinicalTrials.gov

Observational Cohort Study of TachoSil (TC-018-IN)

CompletedOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2008

Conditions
Blood Loss, Surgical
Interventions
DRUG

Fibrinogen (human) + thrombin (human) (TachoSil)

treatment in surgery for improvement of haemostasis where standard techniques are insufficient

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY

NCT00285623 - Observational Cohort Study of TachoSil (TC-018-IN) | Biotech Hunter | Biotech Hunter